From evidence to action
At ICARS, our mission is to partner with low- and middle-income countries (LMICs) in their efforts to reduce drug-resistant infections.
We do this by co-developing tailored solutions with LMIC governments and researchers, who then implement them on the ground using ICARS funding and expertise, building on AMR National Action Plans.
Follow us and view our latest news
ICARS Strategy 2022 – 2026
Guided by our vision of a world without drug-resistant infections, we have developed a new strategy with a revised outcome framework and refined the scope and goals of each of our interconnected pillars.
We are pleased to present a succinct overview of ICARS unique value proposition, followed by our overarching strategy that will run until 2026, as well as a roadmap that details our planned activities per pillar.
Our projects inform policy and practice around the world
At ICARS, we simultaneously use top-down and bottom-up approaches, engaging with government ministries while involving scientists and practitioners throughout the process.
Join our mission
To achieve sustainable change in LMICs, we invite countries and foundations to join us as Strategic Funding Partners, Funding Partners or Mission Partners, in a truly international effort to mitigate antimicrobial resistance.
Please do not hesitate to contact our team for further information.
Tomorrow! Don't miss the webinar "Vaccines and Antimicrobial Resistance: Considerations for AMR Policy and Practice in LMICS" with OHT's Erta Kalanxhi! WITH @ICARS_global, @IVIHeadquarters, & @DanishMFA!
🗓️ March 23, 9 am GMT
Register: https://ivi-int.zoom.us/webinar/register/WN_9CVCqui3S168U1ICZtmJww?timezone_id=Europe%2FDublin
#AMR #globalhealth
What are the challenges for developing a #OneHealth agenda to tackle #AMR in #Brazil? 🇧🇷
#MondayRead highlights the importance of
👉Working across disciplines & ministries
👉Community & policymaker engagement
👉Developing sustainable governance structures
https://bit.ly/3JSGdjd